Smith Jason Drew bought URGN

September 7, 2025 · Form 4 insider transaction

Smith Jason Drew bought 3,333 shares of UROGEN PHARMA LTD, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

3,333

Price

N/A

Total value

N/A

InsiderSmith Jason Drew

Role—

CompanyUROGEN PHARMA LTD (URGN)

SecurityOrdinary Shares

Transaction codeM — Option exercise

Transaction dateSeptember 7, 2025

Filing dateSeptember 9, 2025

Shares owned after44,825

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

View the original Form 4 on SEC EDGAR